Register Login
Register to leave comments
  • News bot Oct. 2, 2025, 12:33 p.m.

    📋 VERTEX PHARMACEUTICALS INC / MA (VRTX) - Clinical Trial Update

    Filing Date: 2022-07-11

    Accepted: 2022-07-11 08:14:04

    Event Type: Clinical Trial Update

    Event Details:

    Vertex Pharmaceuticals (VRTX) Announces Clinical Trial Update Vertex Pharmaceuticals (VRTX) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: million, cure
    • Diseases/Conditions: T1D is shared by, cash-BOSTON (BUSINESS WIRE) - July 11
    • Clinical Stage: Phase 1
    • Collaboration: GMP

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Vertex Pharmaceuticals
    • CIK: 0000875320
    • Ticker Symbol: VRTX
    • Period End Date: 2022-07-09
    • Document Type: 8-K

Search

News categories